Connection
Edward Gardner to HIV Integrase Inhibitors
This is a "connection" page, showing publications Edward Gardner has written about HIV Integrase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.976 |
|
|
|
-
Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
Score: 0.575
-
Gardner EM, Melendez AG, Astiz M, Bray K. Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase. J Int Assoc Physicians AIDS Care (Chic). 2012 Jan-Feb; 11(1):34-9.
Score: 0.348
-
Kousari AE, Wilson MP, Hawkins KL, Bandali MM, Henao-Mart?nez AF, Gardner EM, Erlandson KM. Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV. HIV Res Clin Pract. 2024 12; 25(1):2339576.
Score: 0.052